WEBULL
WebtradeDownload

Colgate Palmolive (CL) Stock Still Looks Reasonable Following Its 38% Five Year Run

Simply Wall St · 21h ago

Colgate-Palmolive has turned in solid multi-year gains and a fresh run in 2026, so the real question now is whether the cash the business can produce over time lines up with the current share price. With the stock recently around US$95, investors are asking if the underlying cash flows support that level or if expectations have started to stretch.

  • Over the past 5 years, Colgate-Palmolive has returned about 38.0%, which puts real weight on whether that share price climb is matched by its long run cash generation potential.
  • Recent earnings strength, higher margin guidance and increased spending on premium products and advertising may support expectations for steadier cash flow and influence how investors think about the value of those future streams today.
  • What if you looked at Colgate-Palmolive through its earnings instead? See why Colgate-Palmolive's 37.0x P/E tells a different valuation story.

The issue now is whether Colgate-Palmolive's current market value is justified by the intrinsic value suggested by its Discounted Cash Flow (DCF) estimate based on those cash flows.

If you are weighing Colgate-Palmolive against other options where valuation hinges on cash generation, a focused screen of 35 high quality undervalued stocks can provide another structured starting point for research.

Is Colgate-Palmolive Still Cheap on Cash Flow?

The Discounted Cash Flow (DCF) approach here weighs the cash Colgate-Palmolive is expected to generate for shareholders against the current price of US$95.62. Latest twelve-month free cash flow sits at about US$3.77b, and the 2 Stage Free Cash Flow to Equity model assumes that these owner earnings continue to grow rather than shrink over the coming decade.

In the model, projected free cash flows rise gradually and then settle into slower expansion in the later years, which aligns more closely with a mature global consumer products group rather than a high-growth story. Because the DCF projections put Colgate-Palmolive's estimated intrinsic value meaningfully above the current share price, the stock screens as undervalued on this cash flow lens. The Q3 2026 earnings beat, along with higher full-year guidance and firmer margin targets, helps explain why the model supports more value than the present market price embeds. Find out what Colgate-Palmolive could be worth using our Discounted Cash Flow (DCF) estimate.

The Colgate-Palmolive Narrative: What Would Justify Today's Price?

Narratives for Colgate-Palmolive pick up where the DCF puzzle leaves off and spell out which paths for revenue growth, margins and earnings would need to unfold for the stock to be worth meaningfully more or less than today's price, and they sit on Simply Wall St's Community page. Each narrative links a fair value estimate to a defined scenario for Colgate-Palmolive's future catalysts and risks so you can later judge which storyline is actually playing out in real time.

Community views on Colgate-Palmolive split between a premium story driven by mix and margins and a more cautious read on what the current tag already bakes in.

Bull case: 6% undervalued

"Expansion and premiumization of core oral care lines like Colgate Total, now supported by a broader push into premium Oral, Home and Personal Care offerings such as Optic White Pro Series, Fabuloso sprays and premium Palmolive dish pumps, aims to lift pricing power and mix, which can support revenue growth and gross margin..."

Discover why this Narrative puts Colgate-Palmolive at 6% undervalued.

Bear case: 11% overvalued

"This creates a trap worth naming. If you normalise the margin but leave the future multiple at the GAAP-derived figure, you count the adjustment twice and overstate fair value by roughly 45%..."

Explore why this Narrative puts Colgate-Palmolive at 11% overvalued.

One more Colgate-Palmolive angle that could change your view

Colgate-Palmolive's valuation story is only half the picture, because independent checks have also flagged areas of concern that investors may want to inspect closely before feeling comfortable with the risk side. Take a closer look at 3 warning signs before settling on a valuation.